NFA
ITCI

Nationwide Fund Advisors’s Intra-Cellular Therapies Inc. ITCI Stock Holding History

Nationwide Fund Advisors’s Portfolio ITCI Stock Details ITCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-30,965
Closed -$489K – 2214
2017
Q3 		$489K Buy
30,965
+3,037
+11% +$44.6K ﹤0.01% 2199
2017
Q2 		$347K Buy
27,928
+2,099
+8% +$24.3K ﹤0.01% 2367
2017
Q1 		$420K Sell
25,829
-1,681
-6% -$24.3K ﹤0.01% 2247
2016
Q4 		$415K Buy
27,510
+5,013
+22% +$70.8K ﹤0.01% 2274
2016
Q3 		$343K Hold
22,497
– – ﹤0.01% 2359
2016
Q2 		$873K Buy
22,497
+5,223
+30% +$188K ﹤0.01% 1816
2016
Q1 		$480K Sell
17,274
-67
-0.4% -$2.23K ﹤0.01% 2118
2015
Q4 		$933K Buy
17,341
+3,290
+23% +$166K ﹤0.01% 1769
2015
Q3 		$563K Hold
14,051
– – ﹤0.01% 2036
2015
Q2 		$449K Buy
14,051
+880
+7% +$22.3K ﹤0.01% 2308
2015
Q1 		$315K Buy
13,171
+239
+2% +$5.35K ﹤0.01% 2473
2014
Q4 		$228K Sell
12,932
-169
-1% -$2.64K ﹤0.01% 2557
2014
Q3 		$180K Buy
13,101
+177
+1% +$2.66K ﹤0.01% 2746
2014
Q2 		$218K Buy
+12,924
New +$214K ﹤0.01% 2709

Other funds holding ITCI

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
RPAM
Rhenman & Partners Asset Management Stockholm, Sweden $1.06B AUM 52.03% 1-Year Est. Return
SC
Samlyn Capital New York $6.14B AUM 42.05% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Nationwide Fund Advisors's ITCI Position: Q4 2017 in Review

Nationwide Fund Advisors sold out of Intra-Cellular Therapies Inc. (ITCI) in Q4 2017, closing a stake of 30,965 shares — an estimated $489K sold.

Nationwide Fund Advisors first reported a position in ITCI in Q2 2014 and held it in 14 quarters. The position peaked at $933K in Q4 2015. 131 funds tracked by Wall St. Rank hold ITCI as of Q4 2017.

  • Nationwide Fund Advisors reported no remaining Intra-Cellular Therapies Inc. position as of Q4 2017 after selling out during the quarter.
  • Nationwide Fund Advisors sold 30,965 Intra-Cellular Therapies Inc. shares in Q4 2017, an estimated $489K.
  • Nationwide Fund Advisors first reported a position in Intra-Cellular Therapies Inc. in Q2 2014 and held it in 14 quarters.
  • Nationwide Fund Advisors's Intra-Cellular Therapies Inc. position peaked at $933K in Q4 2015.
  • 131 funds tracked by Wall St. Rank held Intra-Cellular Therapies Inc. as of Q4 2017.

Based on Nationwide Fund Advisors's 13F filing for Q4 2017, filed 1 Feb 2018.